Paul J. Clancy

2012

In 2012, Paul J. Clancy earned a total compensation of $3.7M as EVP, Chief Financial Officer at Biogen, a 25% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$18,702
Non-Equity Incentive Plan$607,941
Salary$635,820
Stock Awards$2,287,448
Other$141,584
Total$3,691,495

Clancy received $2.3M in stock awards, accounting for 62% of the total pay in 2012.

Clancy also received $18.7K of change in pension value and nonqualified deferred compensation earnings, $607.9K in non-equity incentive plan, $635.8K in salary and $141.6K in other compensation.

Rankings

In 2012, Paul J. Clancy's compensation ranked 1,829th out of 11,487 executives tracked by ExecPay. In other words, Clancy earned more than 84.1% of executives.

ClassificationRankingPercentile
All
1,829
out of 11,487
84th
Division
Manufacturing
657
out of 4,253
85th
Major group
Chemicals And Allied Products
149
out of 1,203
88th
Industry group
Drugs
83
out of 925
91st
Industry
Biological Products, Except Diagnostic Substances
13
out of 165
92nd
Source: SEC filing on April 30, 2015.

Clancy's colleagues

We found four more compensation records of executives who worked with Paul J. Clancy at Biogen in 2012.

2012

George Scangos

Biogen

Chief Executive Officer

2012

John Cox

Biogen

EVP, Pharmaceutical Operations Technology

2012

Douglas Williams

Biogen

EVP, Research Development

2012

Kenneth DiPietro

Biogen

EVP, Human Resources

You may also like